Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06153836
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Anatomic Stage 0 Breast Cancer AJCC v8
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Neurotization Procedure — PROCEDUREUndergo placement of nerve graft
- Questionnaire Administration — OTHERAncillary studies
- Subcutaneous Mastectomy — PROCEDUREUndergo standard of care NSM
Study Details
This phase II trial tests the willingness of patients undergoing nipple sparing mastectomy (NSM) to enroll in a randomized study of NSM with or without neurotization of the nipple areolar complex (NAC). This trial also compares patient reported outcomes, including quality of life and breast and NAC sexual functionality, for patients undergoing NSM with or without neurotization of the NAC. NSM is a standard practice option for patients undergoing preventative mastectomy, but many report dissatisfaction with decreased nipple sensation. Neurotization is a surgical technique using a nerve graft in an attempt to restore NAC sensation. Neurotization during NSM and reconstruction may restore NAC sensation and improve quality of life in breast cancer patients.
Key Dates
- Start date
- Dec 5, 2023
- Status verified
- Dec 2025
- Primary completion
- Nov 10, 2026
- Completion
- Nov 10, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: ARM I (control)Patients undergo standard of care NSM on study.
- Experimental: ARM II (neurotization)Patients undergo neurotization during standard of care NSM on study.
Primary Outcome Measure
Percentage of patients undergoing nipple sparing mastectomy (NSM) to enroll in a randomized trial of NSM with or without neurotization [ Time Frame: Up to 2 years ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | James W. Jakub, M.D. (PRINCIPAL_INVESTIGATOR) Olivia S. Ho, M.D., M.S. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast CancerRecruiting · Mayo Clinic · Jacksonville, Florida
- Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast CancerRecruiting · Mayo Clinic · Scottsdale, Arizona
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerPHASE3 · Recruiting · SWOG Cancer Research Network · Birmingham, Alabama
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor TherapyRecruiting · Mayo Clinic · Jacksonville, Florida